Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 699

1.

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.

Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM.

Gut. 2004 Sep;53(9):1363-5.

2.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.

Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

PMID:
21719446
3.

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.

Vassilopoulos D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, Manolakopoulos S, Koskinas J, Manesis EK, Archimandritis AI.

Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.

PMID:
20472596
4.

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.

J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.

PMID:
19075267
5.

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.

Shibolet O, Ilan Y, Gillis S, Hubert A, Shouval D, Safadi R.

Blood. 2002 Jul 15;100(2):391-6.

6.

Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy.

Chung SJ, Kim JK, Park MC, Park YB, Lee SK.

J Rheumatol. 2009 Nov;36(11):2416-20. doi: 10.3899/jrheum.081324. Epub 2009 Oct 1. Erratum in: J Rheumatol. 2010 Jan;37(1):216.

PMID:
19797507
7.

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.

Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, Airò P.

J Rheumatol. 2009 Jun;36(6):1188-94. doi: 10.3899/jrheum.081246. Epub 2009 May 15. Review.

PMID:
19447932
8.

Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.

Simpson ND, Simpson PW, Ahmed AM, Nguyen MH, Garcia G, Keeffe EB, Ahmed A.

J Clin Gastroenterol. 2003 Jul;37(1):68-71.

PMID:
12811213
9.

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.

Yeo W, Steinberg JL, Tam JS, Chan PK, Leung NW, Lam KC, Mok TS, Johnson PJ.

J Med Virol. 1999 Nov;59(3):263-9.

PMID:
10502254
10.

[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].

Sugimoto R, Enjoji M, Kotoh K, Noguchi K, Tsuruta S, Nakamuta M, Nawata H.

Fukuoka Igaku Zasshi. 2004 Oct;95(10):274-9. Japanese.

PMID:
15678886
11.

Hepatitis B and C virus infection in Crohn's disease.

Biancone L, Pavia M, Del Vecchio Blanco G, D'Incà R, Castiglione F, De Nigris F, Doldo P, Cosco F, Vavassori P, Bresci GP, Arrigoni A, Cadau G, Monteleone I, Rispo A, Fries W, Mallardi B, Sturniolo GC, Pallone F; Italian Group for the Study of the Colon and Rectum (GISC).

Inflamm Bowel Dis. 2001 Nov;7(4):287-94.

PMID:
11720317
12.

Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.

Carroll MB, Bond MI.

Semin Arthritis Rheum. 2008 Dec;38(3):208-17. doi: 10.1016/j.semarthrit.2007.10.011. Epub 2008 Jan 25. Review.

PMID:
18221983
13.

High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.

Matsue K, Aoki T, Odawara J, Fujiwara H, Iwama K, Kimura S, Yamakura M, Takeuch M.

Eur J Haematol. 2009 Oct;83(4):357-64. doi: 10.1111/j.1600-0609.2009.01291.x. Epub 2009 Jun 8.

PMID:
19508685
14.

Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.

Pérez-Alvarez R, Díaz-Lagares C, García-Hernández F, Lopez-Roses L, Brito-Zerón P, Pérez-de-Lis M, Retamozo S, Bové A, Bosch X, Sanchez-Tapias JM, Forns X, Ramos-Casals M; BIOGEAS Study Group.

Medicine (Baltimore). 2011 Nov;90(6):359-71. doi: 10.1097/MD.0b013e3182380a76.

15.

A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.

Yalcin K, Degertekin H, Yildiz F, Kilinc N.

J Gastroenterol. 2003;38(8):796-800.

PMID:
14505137
16.
17.

Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Francisci D, Falcinelli F, Schiaroli E, Capponi M, Belfiori B, Flenghi L, Baldelli F.

Infection. 2010 Feb;38(1):58-61. doi: 10.1007/s15010-009-9019-1. Epub 2009 Nov 10.

PMID:
19904491
18.

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.

Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M, Takeuchi M.

Cancer. 2010 Oct 15;116(20):4769-76. doi: 10.1002/cncr.25253.

19.
20.

Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature.

Blanpain C, Knoop C, Delforge ML, Antoine M, Peny MO, Liesnard C, Vereerstraeten P, Cogan E, Adler M, Abramowicz D.

Transplantation. 1998 Oct 15;66(7):883-6.

PMID:
9798698

Supplemental Content

Support Center